Backing Off From Brachytherapy? Deciphering the Decline

The declining use of brachytherapy was a much-discussed enigma among radiation oncologists and other experts who attended this year’s European Society for Radiotherapy and Oncology (ESTRO) 3rd Forum. In the face of ample evidence about the benefits and sometimes even dramatic advantages of brachytherapy in the treatment of various cancers, the conversations of researchers and discussants alike drifted repeatedly to the puzzle of brachytherapy’s underuse ― at least in some places.